•
Mar 31, 2023

Mural Oncology Q1 2023 Earnings Report

EPS
-$2.78
R&D Expenses
$40.4M
G&A Expenses
$3.75M
Free Cash Flow
-$56.1M

Mural Oncology

Mural Oncology